Wednesday's Top Analyst Upgrades and Downgrades: Chevron, Clorox, Corsair Gaming, Coursera, Schlumberger, Under Armour and More

Mercury Inc. (NASDAQ: MRCY): Baird downgraded the shares from Outperform to Neutral with a $56 price target. The consensus target is up at $82.14. The shares were last seen on Tuesday at $63.57. The stock was down almost 7% in premarket trading despite earnings and revenue exceeding estimates.

Microvast Holdings Inc. (NASDAQ: MVST): Morgan Stanly started coverage with an Underweight rating and a $6 price target. No consensus target was available. The shares closed Tuesday at $8.45 apiece.

Nautilus Biotechnology Inc. (NASDAQ: NAUT): Goldman Sachs started coverage with a Neutral rating and a $10 price target. No consensus target was available. The final Tuesday trade was reported at $7.65.

Omega Health Investors Inc. (NYSE: OHI): Capital One’s downgrade to Equal Weight from Overweight came with a $38 price target. The consensus target is $40.14. The shares were last seen Tuesday at $34.60, which was down almost 4% despite posting reasonable results.

Schlumberger Ltd. (NYSE: SLB): HSBC Securities raised the oilfield services giant to Hold from Reduce, and the firm has a $25 price target. The higher consensus target is $33.40, and Tuesday’s closing print was $28.90 a share.

Shenandoah Telecommunications Co. (NASDAQ: SHEN): Raymond James raised its Underperform rating to Market Perform. The shares have traded in a 52-week range of $29.43 to $61.53 and have a $43.33 consensus price target. The stock retreated over 7% on Tuesday after the company missed earnings estimates, closing at $29.58.

SolarWinds Corp. (NYSE: SWI): Berenberg downgraded the stock to Hold from Buy and has a $24 price target. The consensus target is $19.38, and the last trade to hit the tape on Tuesday came in at $22.64.

Under Armour Inc. (NYSE: UAA): JPMorgan raised its Neutral rating on the sports apparel giant to Overweight, and the analyst has a $30 price target. The posted consensus target is $25.54. The stock closed trading on Tuesday at $22.70, after an almost 8% pop in the wake of solid second-quarter results.

Four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal market months are right around the corner. They are classic defensive names that will hold up much better than crowded momentum stocks when the inevitable correction comes.

Tuesday’s early top analyst upgrades and downgrades included Airbnb, Krispy Kreme, Old Dominion Freight Line, Planet Fitness, Square, Workday and XPO Logistics. Analyst calls seen later in the day were on Exxon Mobil, First Solar, Tesla and more.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.